Reaction

Metabolic Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,622 reports · 39 co-occurring drugs

As of the last recalculation, Metabolic Syndrome appears in 1,622 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is OLANZAPINE PAMOATE (PRR 83.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Olanzapine Pamoate	228	83.0	83.5
Olanzapine	407	64.6	64.8
Ziprasidone	60	45.4	45.5
Quetiapine Fumarate	90	41.4	41.5
Aripiprazole Oral	123	41.2	41.3
Aripiprazole Orally Disintegrating	123	41.2	41.3
Ziprasidone Mesylate	34	31.2	31.3
Quetiapine	364	31.0	31.0
Aripiprazole	232	28.2	28.3
Haloperidol	51	27.8	27.8
Haloperidol Lactate	51	27.3	27.3
Lithium	47	24.6	24.7
Lithium Bromatum	47	24.6	24.7
Risperidone	216	23.9	23.9
Lithium Carbonate	28	21.5	21.5
Paliperidone	38	21.4	21.4
Tenofovir Disoproxil Fumarate Tablets	11	16.5	16.5
Abacavir Sulfate	12	15.9	15.9
Clozapine	135	15.0	15.0
Cariprazine	10	13.9	13.9
Valproate Sodium	22	13.8	13.8
Divalproex Sodium	44	12.4	12.5
Gemfibrozil	14	11.9	11.9
Darunavir	12	10.3	10.3
Raltegravir	13	10.2	10.2
Fenofibrate	27	9.9	9.9
Quinapril Hydrochloride	6	9.8	9.8
Lurasidone Hydrochloride	13	8.0	8.0
Valproic Acid	18	7.4	7.4
Nevirapine	5	7.1	7.1
Metformin Hcl	30	7.1	7.1
Efavirenz	6	6.9	6.9
Amphetamine	4	6.2	6.2
Calcium, Magnesium, Potassium, And Sodium Oxybates	4	6.0	6.0
Asenapine Maleate	4	5.9	5.9
Tenofovir Disoproxil Fumarate	14	5.5	5.5
Paliperidone Palmitate	13	5.2	5.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	3	3.8	3.8
Guselkumab	8	2.9	2.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.